Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

YB-1 relocates to the nucleus in adenovirus-infected cells and facilitates viral replication by inducing E2 gene expression through the E2 late promoter.

Authors:
Per S Holm Stephan Bergmann Karsten Jurchott Hermann Lage Karsten Brand Axel Ladhoff Klaus Mantwill David T Curiel Matthias Dobbelstein Manfred Dietel Bernd Gansbacher Hans-Dieter Royer

J Biol Chem 2002 Mar 11;277(12):10427-34. Epub 2002 Jan 11.

Institut für Experimentelle Onkologie und Therapieforschung, Technische Universität München, Klinikum Rechts der Isar, München 81675, Germany.

The adenovirus early proteins E1A and E1B-55kDa are key regulators of viral DNA replication, and it was thought that targeting of p53 by E1B-55kDa is essential for this process. Here we have identified a previously unrecognized function of E1B for adenovirus replication. We found that E1B-55kDa is involved in targeting the transcription factor YB-1 to the nuclei of adenovirus type 5-infected cells where it is associated with viral inclusion bodies believed to be sites of viral transcription and replication. We show that YB-1 facilitates E2 gene expression through the E2 late promoter thus controlling E2 gene activity at later stages of infection. The role of YB-1 for adenovirus replication was demonstrated with an E1-minus adenovirus vector containing a YB-1 transgene. In infected cells, AdYB-1 efficiently replicated and produced infectious progeny particles. Thus, adenovirus E1B-55kDa protein and the host cell factor YB-1 act jointly to facilitate adenovirus replication in the late phase of infection.

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M106955200DOI Listing
March 2002

Publication Analysis

Top Keywords

adenovirus replication
12
factor yb-1
8
expression late
8
gene expression
8
late promoter
8
adenovirus
7
replication
6
yb-1
6
inclusion bodies
4
5-infected cells
4
bodies believed
4
type 5-infected
4
produced infectious
4
cells associated
4
viral inclusion
4
infectious progeny
4
associated viral
4
nuclei adenovirus
4
replication e1b-55kda
4
particles adenovirus
4

Altmetric Statistics


Show full details
9 Total Shares
9 Citations

Similar Publications

Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV Challenge.

Authors:
Delphine C Malherbe Lo Vang Jason Mendy Philip T Barnette David A Spencer Jason Reed Bettie W Kareko D Noah Sather Shilpi Pandey Constantinos K Wibmer Harlan Robins Deborah H Fuller Byung Park Samir K Lakhashe James M Wilson Michael K Axthelm Ruth M Ruprecht Penny L Moore Jonah B Sacha Ann J Hessell Jeff Alexander Nancy L Haigwood

Front Immunol 2020 15;11:626464. Epub 2021 Feb 15.

Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States.

Designing immunogens and improving delivery methods eliciting protective immunity is a paramount goal of HIV vaccine development. A comparative vaccine challenge study was performed in rhesus macaques using clade C HIV Envelope (Env) and SIV Gag antigens. One group was vaccinated using co-immunization with DNA Gag and Env expression plasmids cloned from a single timepoint and trimeric Env gp140 glycoprotein from one of these clones (DNA+Protein). Read More

View Article and Full-Text PDF
February 2021
Similar Publications

[Which drugs to treat Adenovirus infections?]

Authors:
Maud Salmona Linda Feghoul Jérôme LeGoff

Virologie (Montrouge) 2021 Feb;25(1):43-56

Université de Paris, Inserm U976, Insight team, F-75010, Paris France Unité Virologie et greffes, Département des agents infectieux, Hôpital Saint-Louis, APHP, F-75010 Paris, France.

Human adenoviruses (HAdV) infections are generally mild and resolve spontaneously in immunocompetent individuals. However, HAdV infections can have a major clinical impact in immunocompromised patients. HAdV infections are associated with high morbidity and mortality in recipients of allogeneic stem cell transplants, particularly children. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Codon Usage and Adenovirus Fitness: Implications for Vaccine Development.

Authors:
Judit Giménez-Roig Estela Núñez-Manchón Ramon Alemany Eneko Villanueva Cristina Fillat

Front Microbiol 2021 10;12:633946. Epub 2021 Feb 10.

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Vaccination is the most effective method to date to prevent viral diseases. It intends to mimic a naturally occurring infection while avoiding the disease, exposing our bodies to viral antigens to trigger an immune response that will protect us from future infections. Among different strategies for vaccine development, recombinant vaccines are one of the most efficient ones. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

A novel fiber-2-edited live attenuated vaccine candidate against the highly pathogenic serotype 4 fowl adenovirus.

Authors:
Quan Xie Shiya Cao Wei Zhang Weikang Wang Luyuan Li Qiuqi Kan Hui Fu Tuoyu Geng Tuofan Li Zhimin Wan Wei Gao Hongxia Shao Aijian Qin Jianqiang Ye

Vet Res 2021 Feb 27;52(1):35. Epub 2021 Feb 27.

Key Laboratory of Jiangsu Preventive Veterinary Medicine, Key Laboratory for Avian Preventive Medicine, Ministry of Education, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, Jiangsu, China.

Recently, the outbreaks of hydropericardium-hepatitis syndrome (HHS) caused by the highly pathogenic fowl adenovirus serotype 4 (FAdV-4) have resulted in huge economic losses to the poultry industry globally. Although several inactivated or subunit vaccines have been developed against FAdV-4, live-attenuated vaccines for FAdV-4 are rarely reported. In this study, a recombinant virus FA4-EGFP expressing EGFP-Fiber-2 fusion protein was generated by the CRISPR/Cas9 technique. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses.

Authors:
Lucas J Kerstetter Stephen Buckley Carly M Bliss Lynda Coughlan

Front Immunol 2020 29;11:607333. Epub 2021 Jan 29.

Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, United States.

It is evident that the emergence of infectious diseases, which have the potential for spillover from animal reservoirs, pose an ongoing threat to global health. Zoonotic transmission events have increased in frequency in recent decades due to changes in human behavior, including increased international travel, the wildlife trade, deforestation, and the intensification of farming practices to meet demand for meat consumption. Influenza A viruses (IAV) possess a number of features which make them a pandemic threat and a major concern for human health. Read More

View Article and Full-Text PDF
January 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap